Abstract
Dendritic cell (DC) based cancer vaccines represent a promising immunotherapeutic strategy against cancer. To enhance the modest immunogenicity of DC vaccines, various adjuvants are often incorporated. Particularly, most of the common adjuvants are derived from bacteria. In the current study, we evaluate the use of a human pancreatic cancer derived protein, pancreatic adenocarcinoma upregulated factor (PAUF), as a novel DC vaccine adjuvant. We show that PAUF can induce activation and maturation of DCs and activate NFkB by stimulating the Toll-like receptor signaling pathway. Furthermore, vaccination with PAUF treated DCs pulsed with E7 or OVA peptides leads to generation of E7 or OVA-specific CD8+ T cells and memory T cells, which correlate with long term tumor protection and antitumor effects against TC-1 and EG.7 tumors in mice. Finally, we demonstrated that PAUF mediated DC activation and immune stimulation are dependent on TLR4. Our data provides evidence supporting PAUF as a promising adjuvant for DC based therapies, which can be applied in conjunction with other cancer therapies. Most importantly, our results serve as a reference for future investigation of human based adjuvants.
References
Aug 11, 1998·Immunity·O AdachiS Akira
Feb 9, 2000·The Journal of Experimental Medicine·R JosienY Choi
Jan 15, 2003·Journal of Leukocyte Biology·Ian D DavisJonathan Cebon
May 4, 2004·Nature Medicine·Carl G FigdorCornelis J M Melief
May 19, 2004·Human Cell·Takashi MorisakiMitsuo Katano
Apr 2, 2005·Nature Reviews. Immunology·Jacques Banchereau, A Karolina Palucka
Apr 19, 2007·Cancer Immunology, Immunotherapy : CII·Ji-Yan LiuYi-Xin Zeng
Jun 28, 2007·The Journal of Gene Medicine·Xiaopeng ZhangWei Chen
Sep 12, 2007·Trends in Immunology·Anna Rubartelli, Michael T Lotze
Mar 24, 2009·Cancer Science·Sun A KimSi Young Song
Sep 29, 2009·Oncogene·Y LeeS S Koh
Aug 31, 2010·Oncogene·H D ParkD-S Lim
Jan 5, 2011·Experimental & Molecular Medicine·Il-Rae ChoYoung-Hwa Chung
Oct 11, 2011·Journal of Hepato-biliary-pancreatic Sciences·Hisahito EndoMitsukazu Gotoh
Dec 27, 2011·Age·Henryk F Urbanski, Krystina G Sorwell
Aug 22, 2012·Oncogene·S J KimS S Koh
Dec 3, 2013·Cancer Immunology, Immunotherapy : CII·Nicola E AnnelsGary Middleton
Jul 6, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·In Duk JungYeong-Min Park
Aug 16, 2014·Journal of Translational Medicine·Rebecca SaenzDavorka Messmer
Citations
Dec 3, 2016·Scientific Reports·Hee Dong HanYeong-Min Park
Jul 7, 2017·Oncoimmunology·Li XiaoMargot Zöller
Jun 25, 2016·Oncotarget·Wei ZhangJun-O Jin
Jun 21, 2016·Oncotarget·Jinhoi SongSeokho Kim
Aug 2, 2017·PloS One·Javier Martinez-UserosJesus Garcia-Foncillas
Apr 2, 2019·Clinical and Translational Medicine·S K DanielV G Pillarisetty
Jun 29, 2016·Oncotarget·Huiting SuLiping Zhang
Dec 17, 2017·Oncotarget·Lu DingXingliang Xiong
Jul 18, 2018·Blood Advances·Derek Hoi-Hang Ho, Roger Hoi-Fung Wong
Jun 2, 2016·Human Vaccines & Immunotherapeutics·Jennifer D ElsterKenneth G Lucas
Oct 17, 2017·Oncotarget·Jing LiXiubao Ren
Aug 17, 2018·Scientific Reports·Chel Hun ChoiStephen M Hewitt
Dec 19, 2020·Open Medicine·Haotian LuYing Liu
Dec 11, 2020·Experimental & Molecular Medicine·Gun-Young JangYeong-Min Park
Mar 25, 2020·Life Sciences·Mahsa SadeghzadehDariush Shanehbandi